Chlorambucil

Chloraminophene Chlorobutine

Therapeutic Indications

Chlorambucil is indicated for:

Hodgkin's disease

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 0.2 mg/kg once daily

Μη Hodgkin λέμφωμα

Irrespective of gender only Children (1 year - 12 years old) , Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 0.1-0.2 mg/kg once daily

Waldendstorm's macroglobulinaemia

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 2-12 mg once daily

Chronic lymphocytic leukaemia

Irrespective of gender only Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 0.1-0.15 mg/kg once daily

Contraindications

Active ingredient Chlorambucil is contraindicated in the following cases:

Hypersensitivity to chlorambucil

No gender/age discrimination